Hong Kong scientist behind artificial ‘mini-hearts’ takes Novoheart closer to China with facilities to quicken drug discovery process

Novoheart, the firm behind artificial “mini-hearts,” is expanding in Hong Kong and mainland China to commercialise a technology that can quicken drug discovery process.
( read original story …)

---